Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cell Discovery|July 28, 2016
The ERK signaling target RNF126 regulates anoikis resistance in cancer cells by changing the mitochondrial metabolic fluxSeiko Yoshino, Toshiro Hara, Hiroki J Nakaoka, et al.Scientific Reports|November 25, 2016
Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virusTakayuki Uematsu, Tomoko Fujita, Hiroki J Nakaoka, et al.Proceedings of the National Academy of Sciences of the United States of America|May 17, 2017
Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytesToshiro Hara, Hiroki J Nakaoka, Tetsuro Hayashi, et al.Scientific Reports|March 8, 2016
NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer CellsHiroki J Nakaoka, Toshiro Hara, Seiko Yoshino, et al.Oncogene|August 3, 2018
Hippo signaling dysfunction induces cancer cell addiction to YAPHan Han, Bing Yang, Hiroki J Nakaoka, et al.Molecular Cell|October 9, 2018
Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein InteractionHan Han, Ruxi Qi, Jeff Jiajing Zhou, et al.Molecular Cancer Therapeutics|August 28, 2020
Nf1-Mutant Tumors Undergo Transcriptome and Kinome Remodeling after Inhibition of either mTOR or MEKDaniela Pucciarelli, Steven P Angus, Benjamin Huang, et al.Plos Biology|September 22, 2022
Primary and metastatic tumors exhibit systems-level differences in dependence on mitochondrial respiratory functionNeal K Bennett, Hiroki J Nakaoka, Danny Laurent, et al.Nature Communications|August 30, 2020
Defining the ATPome reveals cross-optimization of metabolic pathwaysNeal K Bennett, Mai K Nguyen, Maxwell A Darch, et al.Nature Cell Biology|January 14, 2022
The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1Han Han, Hiroki J Nakaoka, Line Hofmann, et al.Pageof 2